Dose conversion and titration with a novel, once-daily, OROS® osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain

Mark Palangio, Donald W. Northfelt, Russell K. Portenoy, Daniel Brookoff, Ralph T. Doyle, Bruce E. Dornseif, Michael C. Damask

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Dose conversion and titration with a novel, once-daily, OROS® osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain'. Together they form a unique fingerprint.

Medicine & Life Sciences